Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: A randomized, prospective, controlled trial

Contributions to Nephrology

Volumn 181, Issue , 2013, Pages 152-162

  Xu, Jing ^a   Zhang, Wen ^a   Xu, Yaowen ^a   Shen, Pingyan ^a   Ren, Hong ^a   Wang, Weiming ^a   Li, Xiao ^a   Pan, Xiaoxia ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 84958664445     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000348475     Document Type: Article

References (24)

1. Glassock RJ: The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010; 56:157-167.
2. Hitoshi Y, Takashi T, Hitoshi S, et al: Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2012; 16:557-563.
3. Zhou FD, Zhao MH, Zou WZ, Liu G, Wang H: The changing spectrum of primary glo-merular diseases within 15 years: a survey of 3, 331 patients in a single Chinese centre. Nephrol Dial Transplant 2009; 24:870-876.
4. Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13, 519 renal biopsies. Kidney Int 2004; 66:920-923.
5. Schieppati A, Mosconi L, Perna A, et al: Prognosis of untreated patients with idio-pathic membranous nephropathy. N Engl J Med 1993;329: 85-89. (Pubitemid 23188821)
6. Honkanen E, Tornroth T, Gronhagen-Riska C: Natural history, clinical course and morphological evolution of membranous ne-phropathy. Nephrol Dial Transplant 1992; 7(suppl 1):35-41. (Pubitemid 23016765)
7. KDIGO Clinical Practice Guideline for Glo-merulonephritis. Kidney Int Suppl 2012; 2: 143-153.
8. Westhoff TH, van der Giet M: Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs 2007; 16: 1099-1110. (Pubitemid 47074164)
9. Praga M, Barrio V, Juárez GF, et al: Tacroli-mus monotherapy in membranous nephrop-athy: a randomized controlled trial. Kidney Int 2007; 71:924-930. (Pubitemid 46663803)
10. Levey AS, Coresh J, Greene T, et al: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247-254. (Pubitemid 46768608)
11. Segal PE, Choi MJ: Recent advances and prognosis in idiopathic membranous ne-phropathy. Adv Chronic Kidney Dis 2012; 19: 114-119.
12. Hofstra JM, Branten AJ, Wirtz JJ, et al: Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial. Nephrol Dial Transplant 2010; 25:129-136.
13. Ponticelli C, Passerini P: Management of id-iopathic membranous nephropathy. Expert Opin Pharmacother 2010; 11:2163-2175.
14. Thomson AW: FK506. How much potential. Immunol Today1989; 10:6-9.
15. Jardine AG: Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transpl Int 2005; 18:379-384. (Pubitemid 41726870)
16. Artz MA, Boots JMM, Ligtenberg G, et al: Conversion from cyclosporine to tacrolimus improves quality of life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004; 4:937-945. (Pubitemid 38745593)
17. Min C, Hang L, Xia-Yu L, et al: Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous ne-phropathy: a multicenter randomized controlled trial. Am J Med Sci 2010; 339:233-238.
18. Cattran DC, Appel GB, Hebert LA, et al: Cy-closporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001; 59:1484-1490. (Pubitemid 32281239)
19. He L, Peng Y, Liu H: Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. J Nephrol 2012 (E-pub ahead of print).
20. Schieppati A, Mosconi L, Perna A, et al: Prognosis of untreated patients with idio-pathic membranous nephropathy. N Engl J Med 1993; 329:85-89. (Pubitemid 23188821)
21. Donadio JV, Torres VE, Velosa JA, et al: Id-iopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988;33: 708-715. (Pubitemid 18083120)
22. Glassock RJ: The therapy of idiopathic membranous glomerulonephritis. Semin Nephrol 1991; 11:138-147.
23. Polanco N, Gutiérrez E, Rivera F, et al: Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transplant 2012; 27:231-234.
24. Ruggenenti P, Chiurchiu C, Brusegan V, et al: Rituximab in idiopathic membranous ne-phropathy: a one-year prospective study. J Am Soc Nephrol 2003; 14:1851-1857. (Pubitemid 36750480)